SE423813B - Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper - Google Patents
Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaperInfo
- Publication number
- SE423813B SE423813B SE7708642A SE7708642A SE423813B SE 423813 B SE423813 B SE 423813B SE 7708642 A SE7708642 A SE 7708642A SE 7708642 A SE7708642 A SE 7708642A SE 423813 B SE423813 B SE 423813B
- Authority
- SE
- Sweden
- Prior art keywords
- pyrrolidons
- disubstituted
- procedure
- preparation
- therapeutical properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71236276A | 1976-08-06 | 1976-08-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7708642L SE7708642L (sv) | 1978-02-07 |
| SE423813B true SE423813B (sv) | 1982-06-07 |
Family
ID=24861795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7708642A SE423813B (sv) | 1976-08-06 | 1977-07-27 | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper |
Country Status (31)
| Country | Link |
|---|---|
| JP (2) | JPS5321159A (cs) |
| AR (1) | AR217080A1 (cs) |
| AT (1) | AT362887B (cs) |
| AU (1) | AU508007B2 (cs) |
| BE (1) | BE857506A (cs) |
| BG (1) | BG31073A3 (cs) |
| CA (1) | CA1077948A (cs) |
| CH (1) | CH624934A5 (cs) |
| CS (1) | CS221269B2 (cs) |
| DD (2) | DD143768A5 (cs) |
| DE (1) | DE2735904A1 (cs) |
| DK (1) | DK352077A (cs) |
| ES (2) | ES461388A1 (cs) |
| FI (1) | FI70009C (cs) |
| FR (1) | FR2369260A1 (cs) |
| GB (2) | GB1556569A (cs) |
| GR (1) | GR68688B (cs) |
| HU (1) | HU180273B (cs) |
| IE (1) | IE45505B1 (cs) |
| IL (1) | IL52615A (cs) |
| LU (1) | LU77936A1 (cs) |
| NL (1) | NL7708637A (cs) |
| NO (1) | NO772752L (cs) |
| NZ (1) | NZ184806A (cs) |
| PH (1) | PH17398A (cs) |
| PL (2) | PL112931B1 (cs) |
| PT (1) | PT66891B (cs) |
| SE (1) | SE423813B (cs) |
| SU (3) | SU703016A3 (cs) |
| YU (1) | YU192577A (cs) |
| ZA (1) | ZA774704B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5695569A (en) * | 1979-12-27 | 1981-08-03 | Canon Inc | Forming method for bar lens sphere face |
| US4321201A (en) * | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
| JPS59137224A (ja) * | 1983-01-25 | 1984-08-07 | Mitsubishi Electric Corp | 電気鉄道用き電電圧補償装置 |
| ATE327751T1 (de) | 2000-01-31 | 2006-06-15 | Pfizer Prod Inc | Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz |
| WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| PT1339678E (pt) * | 2000-11-27 | 2007-11-30 | Pfizer Prod Inc | Agonistas selectivos do receptor ep4 no tratamento de osteoporose |
| TWI313608B (en) * | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| MXPA04005555A (es) * | 2002-03-18 | 2005-05-16 | Pfizer Prod Inc | Procedimientos de tratamiento con agonistas selectivos del receptor ep4. |
| US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| US7256211B1 (en) * | 2003-01-21 | 2007-08-14 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivatives and medical use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| JPS511460A (en) * | 1974-06-24 | 1976-01-08 | Tanabe Seiyaku Co | 22 piroridonjudotaino seiho |
| JPS514166A (ja) * | 1974-06-28 | 1976-01-14 | Tanabe Seiyaku Co | 22piroridonjudotaino seiho |
| US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
| DE2528664A1 (de) * | 1975-06-27 | 1977-01-13 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
-
1977
- 1977-07-27 CA CA283,598A patent/CA1077948A/en not_active Expired
- 1977-07-27 SE SE7708642A patent/SE423813B/xx unknown
- 1977-07-28 IL IL52615A patent/IL52615A/xx unknown
- 1977-07-28 GR GR54058A patent/GR68688B/el unknown
- 1977-08-01 AU AU27515/77A patent/AU508007B2/en not_active Expired
- 1977-08-02 NZ NZ184806A patent/NZ184806A/xx unknown
- 1977-08-02 PH PH20060A patent/PH17398A/en unknown
- 1977-08-04 NL NL7708637A patent/NL7708637A/xx not_active Application Discontinuation
- 1977-08-04 PT PT66891A patent/PT66891B/pt unknown
- 1977-08-04 ZA ZA00774704A patent/ZA774704B/xx unknown
- 1977-08-05 CH CH964677A patent/CH624934A5/fr not_active IP Right Cessation
- 1977-08-05 ES ES461388A patent/ES461388A1/es not_active Expired
- 1977-08-05 BG BG037109A patent/BG31073A3/xx unknown
- 1977-08-05 YU YU01925/77A patent/YU192577A/xx unknown
- 1977-08-05 SU SU772511155A patent/SU703016A3/ru active
- 1977-08-05 GB GB33002/77A patent/GB1556569A/en not_active Expired
- 1977-08-05 FI FI772376A patent/FI70009C/fi not_active IP Right Cessation
- 1977-08-05 HU HU77PI587A patent/HU180273B/hu unknown
- 1977-08-05 IE IE1641/77A patent/IE45505B1/en unknown
- 1977-08-05 FR FR7724290A patent/FR2369260A1/fr active Granted
- 1977-08-05 DK DK352077A patent/DK352077A/da not_active Application Discontinuation
- 1977-08-05 AR AR268699A patent/AR217080A1/es active
- 1977-08-05 DD DD77213369A patent/DD143768A5/de unknown
- 1977-08-05 NO NO772752A patent/NO772752L/no unknown
- 1977-08-05 LU LU77936A patent/LU77936A1/xx unknown
- 1977-08-05 DE DE19772735904 patent/DE2735904A1/de not_active Ceased
- 1977-08-05 DD DD77200468A patent/DD136135A5/xx unknown
- 1977-08-05 BE BE1008318A patent/BE857506A/xx not_active IP Right Cessation
- 1977-08-05 GB GB43588/78A patent/GB1556570A/en not_active Expired
- 1977-08-05 CS CS775202A patent/CS221269B2/cs unknown
- 1977-08-06 JP JP9458977A patent/JPS5321159A/ja active Granted
- 1977-08-08 PL PL1977215666A patent/PL112931B1/pl unknown
- 1977-08-08 AT AT0579477A patent/AT362887B/de not_active IP Right Cessation
- 1977-08-08 PL PL77200124A patent/PL200124A1/xx unknown
-
1978
- 1978-07-01 ES ES471349A patent/ES471349A1/es not_active Expired
- 1978-10-11 SU SU782672200A patent/SU818480A3/ru active
- 1978-10-17 SU SU782674602A patent/SU850000A3/ru active
-
1979
- 1979-09-03 JP JP54112743A patent/JPS585196B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO803851L (no) | Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose | |
| SE435059B (sv) | Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar | |
| SE441827B (sv) | Forfarande for framstellning av fenoxiaminopropanoler | |
| NO146394C (no) | Analogifremgangsmaate til fremstilling av 1,2-difenyl-3-(imidazol-1-yl)-propan-2-oler med terapeutisk virkning | |
| NO774404L (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| AR224095A1 (es) | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 | |
| NO148959C (no) | Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144 | |
| SE441354B (sv) | Forfarande for framstellning av meta-fenoxibensaldehyd | |
| SE435387B (sv) | Forfarande for framstellning av antracyklinglykosider | |
| NO143992C (no) | Fremgangsmaate for fremstilling av heksanitrostilben | |
| SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
| NO151365C (no) | Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater. | |
| SE423813B (sv) | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper | |
| NO770619L (no) | Fremgangsm}te for fremstilling av 2,3-substituerte-5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning | |
| SE436026B (sv) | Forfarande for framstellning av 13,14-dehydroprostaglandiner | |
| RO75589A (ro) | Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei | |
| SE434263B (sv) | Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan | |
| NO771870L (no) | Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd | |
| SE7707471L (sv) | Forfarande for framstellning av 5-m-tolyloxiuracil | |
| SE7804878L (sv) | Forfarande for framstellning av 1,2-dikloretan | |
| SE7707125L (sv) | Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner | |
| SE7712218L (sv) | Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner | |
| NO771263L (no) | Fremgangsm}te for fremstilling av indol-naftyridin-derivater | |
| SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
| SE7601605L (sv) | Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol |